Kobe Ginobili
12 years ago
GREY MKT
Investors are advised that OTC Markets Group has been unable to contact or confirm the location of this company. If you have current contact information, please complete the Update Company Information Form or send an email to info@otcmarkets.com.
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Deregistered a/o Mar 22, 2007
Latest Report Not Available
Regulatory Agency Not Available
CIK 0001098960
Fiscal Year End Not Available
OTC Market Tier Grey Market
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers
Not Available
Company Directors
Not Available
Company Notes
Formerly=Interallied Group, Inc. until 12-01. State of Incorporation Nevada changed to Delaware concurrent with name change.
Formerly=Interallied Restaurant Group, Inc. until 11-99
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
PLTT Security Details
Share Structure
Market Value1 $12,699 a/o Sep 21, 2012
Shares Outstanding 11,544,501 a/o Jul 31, 2003
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders
Shareholders of Record Not Available
Security Notes
Note=Trading temporarily suspended by the SEC pursuant to Section 12(k) of the Securities and Exchange Act of 1934 from 9:30 AM EST on 05/14/2012 through 11:59 PM EST on 05/25/2012.
Capital Change=shs increased by 1 for 20 split.. Pay date=10/01/1998.
Short Selling Data
Short Interest 0 (-100%)
Apr 29, 2011
Significant Failures to Deliver No
Transfer Agent(s)
American Stock Transfer & Trust Company
SSP
15 years ago
PLTT is the parent company of Gene Smart Health
http://www.genesmart.com/
Scott Derks, Chief Operations Officer. Scott combines the practical skills of a veteran banker with the creative drive of an award winning writer who has authored 14 books. He spent 20 years managing cultural change, profitability and merger activity during the consolidation of the banking industry in the 1980s and 1990s. During his last three years in banking, he served as a senior executive with Bank of America and Chief of Staff to the company's flagship North Carolina and South Carolina operation.
.
Scott is credited with orchestrating the renaissance of Pilot Therapeutics Holdings, Inc., the parent company of Gene Smart Health, from dormancy to its relaunch first as a consultant, then as President. During that time he focused on establishing a commercial foundation for the company in partnership with Wake Forest Medical University.
Scott’s most recent book is The Revolutionary War to the Civil War, his ninth book in the series. He also serves on the board of CIVISonLine, an internet company working with the BBC, New York Times and Yahoo to create the "global conversation.”
http://www.genesmart.com/pages/leadership_team/107.php
SSP
15 years ago
Innovative New Wellness and Nutrition Program Leverages Latest Understanding of Relationship Between Diet and Genes
Innovative New Wellness and Nutrition Program Leverages Latest Understanding of Relationship Between Diet and Genes
Gene Smart(TM) Takes New Approach to Diet and Exercise to Live Longer, Healthier Lives
WINSTON-SALEM, N.C., June 11 /PRNewswire/ -- The mismatch between today's typical diets and our genes has been a major contributor to the nation's health crisis, including obesity and chronic inflammatory disease. Shifting the paradigm to focus on gene-based strategies to nutrition and lifestyle is the goal of Gene Smart Wellness, and its ground-breaking new approach to health and fitness announced today.
The Gene Smart Program officially debuted this week with the publication of The Gene Smart Diet (Rodale Books, June 2009) by Floyd H. "Ski" Chilton, PhD, a pioneer in the study of gene-based nutrition and inflammatory diseases, as well as the launch of a comprehensive new health and wellness web site (www.genesmart.com). Genesmart.com features numerous tools and resources such as diet tips, exercise programs, recipes, nutritional supplements, and motivational success stories to educate consumers and help them get started on the program.
The Gene Smart Program is based on the groundbreaking research of Dr. Chilton, a professor of Physiology and Pharmacology at Wake Forest University School of Medicine, Director of the NIH-sponsored Wake Forest Center for Botanical Lipids, and Senior Associate Director for Research for the Program for Complementary and Integrative Medicine at Wake Forest University Baptist Medical Center. Recent findings suggest our diets and lifestyles are working against our genes rather than with them, resulting in a net effect that has been devastating to our waistlines, not to mention our overall health.
"Clearly, the research has pointed to the typical American diet as the cause of numerous health issues, from obesity to chronic inflammatory diseases," said Dr. Chilton. "But through proven principles that use our bodies' own survival systems, we can start to reverse that trend and help people to not only lose weight, but prevent a host of diseases and live healthier, more vigorous lives."
Dr. Chilton's latest research in nutrient/gene interactions, as published in the June 5, 2009 issue of Journal of Biological Chemistry, has played a role in the development of the Gene Smart Program, which focuses on five key principles:
1. Increase Polyphenols -- Eat more dark-skinned fruits and vegetables. Drink more 100% fruit juices, green tea, red wine and dark chocolate.
2. Add Omegas -- Increase Omega-3 consumption, targeting 1,250 - 1,500 mg of combined EPA and DHA acid per day by eating more fish and through a high quality fish oil supplement. Add 400 - 500 mg daily of a specific omega-6 called GLA.
3. Increase Fiber -- Increase daily fiber consumption to 14-16 grams for every 1,000 calories consumed, or about 30 grams of fiber for a 2,000 calorie diet.
4. Reduce Calories -- If you are overweight, reduce your daily caloric intake by 20% to 30% of what is needed to maintain your current weight.
5. Exercise to Reduce Inflammation -- Exercise at least 5 days a week, for at least 30 minutes, in a specific manner focused on reducing whole body inflammation.
Gene Smart is one of the few wellness programs proven to work in a clinical study. In addition to hundreds of clinical trials from established medical institutions supporting the individual elements of the Gene Smart Program, Dr. Chilton's research laboratory recently completed an eight-week long clinical study on 68 individuals of all shapes and sizes. Participants following the Gene Smart program lost weight, decreased whole body inflammation, reduced risk of disease, and reported improvements in mood and energy.
Gene Smart(TM) Wellness (GSW) is a science-based preventative health care company that combines expertise in consumer marketing, behavioral science, and the science of nutrition, inflammation, gene expression and health. GSW develops, markets, and implements programs and supporting products that empower individuals to prevent disease and improve overall health in order to live life abundantly. More information on the Gene Smart program is available at www.genesmart.com.
Website: http://www.genesmart.com
http://sev.prnewswire.com/health-care-hospitals/20090611/CG3091111062009-1.html
MWM
16 years ago
Nutrition-based therapies to prevent and treat targeted, chronic inflammatory conditions in companion animals
Similar dynamics contributing to chronic inflammatory diseases in humans can be seen in our pets.
It is estimated that 40% of dogs in America are overweight or obese. With a trend towards humanization of pets, owners are increasingly interested in nutrition-based therapies for their pets that are proven effective, safe, and without side effects.
Based on our discoveries utilizing our Gene Smart Nutrigenomics Discovery platform, we are developing a pipeline of products to address the growing need worldwide for safe, gentle, and potent therapies to manage targeted chronic inflammatory diseases in companion animals with products containing combinations of natural bioactives.
MWM
16 years ago
Functional foods and beverages to help prevent and manage targeted chronic inflammatory conditions
As consumers increasingly seek to take control of their own health, they are looking to foods and beverages to deliver meaningful health benefits while fitting into their everyday routines.
At the same time, there is a growing consumer awareness of the connection between whole body inflammation and health.
Utilizing our Gene Smart Nutrigenomics Discovery platform, we are developing a pipeline of nutrition-based food and beverage products to address the growing need worldwide for safe, gentle, and effective products to help prevent and manage targeted, chronic inflammatory conditions.
These products are based on combinations of natural bioactives and are designed for launch under a food or medical food regulatory approach.
MWM
16 years ago
Dedicated to the prevention & treatment of chronic inflammatory conditions
Chronic inflammation contributes to many of the largest and most serious conditions impacting our health today
It is estimated that in the United States alone half the population is affected by diseases associated with chronic inflammation. These conditions include heart disease, diabetes, arthritis, digestive disorders, asthma, allergies, eczema, psoriasis and many others.
Through our Gene Smart Nutrigenomics Discovery Platform, we examine the influence of natural bioactives on the expression of genes that control the inflammatory process. Utilizing this technology, we are developing a robust pipeline of patent-protected products for the prevention and treatment of targeted chronic inflammatory disorders in humans and animals. These products are designed for the Over-the-Counter (OTC), Functional Food & Beverage, and Veterinary Medical Food markets.
Our product platforms are brought to the U.S. and global markets through strategic partnerships with market leaders seeking to establish major new growth platforms.
Our first product was an OTC medical food for the dietary management of asthma based on a proprietary combination of natural fatty acids. We developed and tested the product through five clinical trials to validate safety and efficacy, and licensed it to Efficas, a Colorado-based consumer focused health-science and technology company (www.efficas.com).
SSP
16 years ago
Interesting,
David Mastroianni
* David has been responsible for some of the most successful examples of growth and innovation in natural product companies, brands and products. He was President of Unicity, the global network marketing division of the Dutch multinational Royal Numico. During his tenure, revenues increased from $118 million to over $300 million. He opened and served as the General Manager of the Japan which became the #1 market for the company and lead the development of over $200 million in new nutritional and personal care products.
* David was Executive Vice President of Weider Nutrition, a major branded consumer nutrition products company, when revenues grew from $47 million to over $320 million culminating with a successful IPO in May 1997. He was a board member and CEO of Pacific Health Labs, a public company focused on nutrition technology.
* David holds a B.S. in Nutritional Science from The University of Arizona, and is currently CEO of Vital Foods USA and a principal in the consulting firm he founded in 1999, Natural Growth LLC
SSP
16 years ago
Whoops I found a press release that's dated this Wednesday!
http://www.genesmarthealth.com/19.html
Pilot Therapeutics Announces Relaunch as Gene Smart Health
June 18, 2008
WINSTON-SALEM, N.C. - Pilot Therapeutics Holdings, Inc. today announced the relaunch of Pilot Therapeutics as Gene Smart Health.
As an innovator in gene-based nutrition, Gene Smart Health uniquely combines breakthrough scientific innovation and an in-depth understanding of the health, food, nutrition, and wellness markets to create major new businesses that empower individuals to take care of their health and live life abundantly.
“Through the scientific leadership of our Founder and Chief Science Officer, Dr. Floyd ‘Ski’ Chilton, we are at the forefront in understanding relationships between nutrition, gene expression, inflammation and health,” said Ross Consaul, CEO of Gene Smart Health.
The company is developing three distinct businesses: Gene Smart Therapeutics, Gene Smart Ingredients, and Gene Smart Wellness.
“Our world’s health crisis, with unprecedented levels of obesity accompanied by dramatic increases in chronic inflammatory conditions, is a bold call for action for science-based innovations in prevention, nutrition and wellness,” said Keith Wakeman, President of Gene Smart Health. “Revolutionary advances in our understanding of both nutrition and the human genome provide us with new tools to begin to address these enormous problems.”
Gene Smart Therapeutics is developing a pipeline of over the counter (OTC) products, functional foods & beverages, and veterinary medical foods to prevent and treat chronic inflammatory conditions; Gene Smart Ingredients creates science-based ingredients to improve the healthfulness of the world’s food supply; and Gene Smart Wellness integrates prevention into healthcare through clinically validated wellness programs.
“This relaunch is an important milestone that sets the stage for the future of our company,” said Dr. Chilton.
http://www.genesmarthealth.com
###
Gene Smart Health is a Health and Wellness Innovation Company that creates new businesses that empower individuals to take care of their health and live life abundantly.
Through its Gene Smart Nutrigenomics Discovery Platform, the company examines the influence of natural bioactives on the expression of genes that control the inflammatory process related to numerous chronic inflammatory conditions in humans and animals.
Gene Smart Health is a subsidiary of Pilot Therapeutics Holdings, Inc., a company founded by Dr. Floyd “Ski” Chilton, Professor of Physiology and Pharmacology at Wake Forest University School of Medicine. Dr. Chilton is also director of the Wake Forest and Brigham and Women’s Center for Botanical Lipids which is supported by a grant from the National Center for Complementary and Alternative Medicine and the Office of Dietary Supplements. http://www.mydietaryfats.org
SSP
16 years ago
Main page used to say,
Pioneering health, naturally
Welcome to Pilot Therapeutics
Pilot Therapeutics Inc. is a specialty pharmaceutical company dedicated to benefiting humanity by introducing clinically proven and novel medical food products for the management of chronic human and animal diseases. Pilot's goal is to develop over the counter ("OTC"), medical foods to address a growing need worldwide for safer and gentler therapies that manage inflammatory diseases such as asthma, arthritis diabetes and heart disease. Because of the chronic, long term nature of these diseases, these populations require higher levels and more complex regimens of medications, placing them at higher risks for adverse side effects. This has lead to major dissatisfaction with current treatments and a strong desire by patients to take control of their own disease. These developments have markedly increased the demand for newer therapies with improved safety profiles. Pilot is uniquely positioned to meet this demand by developing breakthrough OTC medical foods for the marketplace. Pilot is a dynamic company, committed to the advancement of medicine and corporate growth.
now it reads,
Pioneering health, naturally
Pilot Therapeutics: Dedicated to the Prevention and Treatment of Chronic Inflammatory Diseases
Whole body inflammation contributes to many of the largest and most serious chronic conditions impacting our health today including asthma, allergies, arthritis, diabetes, and heart disease.
Pilot Therapeutics Inc. is a Nutritional Therapeutics Innovation Company dedicated to the prevention and treatment of chronic inflammatory diseases. As an innovation company Pilot uniquely combines world-class technical innovation capabilities with extensive market-led innovation expertise to develop science-based nutritional product platforms that are well positioned to succeed in the marketplace.
Through its Functional LiponomicsTM discovery platform, Pilot examines the influence of fatty acids on the expression of genes that control the inflammatory and allergic process. Utilizing this technology, Pilot has developed a robust pipeline of clinically validated medical foods for the prevention and treatment of numerous chronic inflammatory disorders in humans and animals. These innovative products are based on over 60 issued and pending domestic and international patents.
Level up your trading with our powerful tools and real-time insights all in one place.
Renee
12 years ago
Wildbilly
12 years ago
EdF
15 years ago
Hot Features
Premium
